Applications focused on LC/HRMS - page 8

Quantification of Semaglutide in Human Plasma Using a Benchtop Multi-reflecting Time-of-Flight Mass Spectrometer

Applications
| 2025 | Waters
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma, Clinical Research

Accelerating GLP-1 Development with High- Throughput LC-MS Using the BioAccord™ LC MS System and the INTACT Mass Application

Applications
| 2025 | Waters
LC/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma

Increased Identification Confidence for Extractables Screening Using the Xevo™ MRT Mass Spectrometer

Applications
| 2025 | Waters
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma

Investigating Drug Metabolism of Methapyrilene Within a Rat Model Using a Data Dependent Acquisition Workflow with the Xevo MRT Mass Spectrometer

Applications
| 2025 | Waters
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma, Clinical Research

Oligo Mapping of sgRNA Digests: Leveraging Xevo MRT Mass Spectrometer Performance and Streamlining Data Analysis

Applications
| 2025 | Waters
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma

Tof MRM for the Quantification of Peptide Biomarkers in Human Glioblastoma with the Xevo™ MRT Mass Spectrometer

Applications
| 2025 | Waters
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, LC/QQQ
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, LC/QQQ
Manufacturer
Waters
Industries
Pharma & Biopharma

Streamlined Characterization of Recombinant AAVs via Charge Detection Mass Spectrometry: Insights from the USP AAV8 Reference Standards

Applications
| 2025 | Waters
LC/MS, LC/MS/MS, LC/IT, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/IT, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma

Advancing ADC Characterization: SECBased Native DAR and Drug Distribution Analysis Using Multi-Reflecting TOF-MS and INTACT Mass Application

Applications
| 2025 | Waters
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma

Expanding the Antibody-Oligo Conjugate (AOC) Characterization Toolbox: Part 2- Denaturing and Non-denaturing Analysis of siRNA Payload

Applications
| 2025 | Waters
LC/MS, LC/MS/MS, LC/HRMS, LC/TOF
Instrumentation
LC/MS, LC/MS/MS, LC/HRMS, LC/TOF
Manufacturer
Waters
Industries
Pharma & Biopharma

Expanding the Antibody-Oligo Conjugate (AOC) Characterization Toolbox: Part 3- Partial and Complete AOC Conjugation Site Determination

Applications
| 2025 | Waters
GPC/SEC, LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
GPC/SEC, LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike